- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Comprehensive Cancer Center (UAB CCC) Birmingham, Alabama, United States
- Novant Health Cancer Institute Winston-Salem, North Carolina, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Liverpool Hospital Liverpool, New South Wales, Australia
Clinical trial condition
Post- Essential Thrombocythemia Myelofibrosis
Explore clinical trials studying Post- Essential Thrombocythemia Myelofibrosis. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Post- Essential Thrombocythemia Myelofibrosis trial results
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States